GeoVax Labs (GOVX) Accounts Payables (2010 - 2026)
GeoVax Labs (GOVX) posted quarterly Accounts Payables of $1.8 million for Q2 2026, little changed year-over-year from $1.8 million in Q2 2025, and up 131.96% quarter-over-quarter from $790750.0 in Q4 2025.
GeoVax Labs (GOVX) Accounts Payables (2010 - 2026) Analysis & Trends
GeoVax Labs (GOVX) has reported Accounts Payables for 17 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Accounts Payables changed 0.22% year-over-year to $1.8 million; the TTM figure through Jun 2026 stood at $1.8 million (changed 0.22% YoY), while the FY2025 annual figure was $790750.0, down 57.25% from the prior year.
- Accounts Payables climbed to $1.8 million in Q2 2026 per GOVX's latest filing, from $790750.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $4.2 million in Q3 2023 and bottomed at $237315.0 in Q2 2022.
- Historically, Accounts Payables has averaged $1.8 million across 5 years, with a median of $1.8 million in 2025.
- Annual changes were most pronounced in 2024 — Accounts Payables surged 357.3% — and 2025, when it tumbled 57.25%.
- GeoVax Labs' Accounts Payables stood at $1.7 million in 2022, then soared by 60.38% to $2.8 million in 2023, then plunged by 34.01% to $1.8 million in 2024, then sank by 57.25% to $790750.0 in 2025, then surged by 131.96% to $1.8 million in 2026.
- Business Quant data shows GOVX's Accounts Payables at $1.8 million in Q2 2026, $790750.0 in Q4 2025, and $976411.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - | 1.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Mn |
| Dec 31, 2025 | 790,750.00 |
| Sep 30, 2025 | 976,411.00 |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 3.98 Mn |
| Mar 31, 2024 | 1.88 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 4.21 Mn |
| Jun 30, 2023 | 871,131.00 |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 237,315.00 |
| Mar 31, 2022 | 426,103.00 |
| Dec 31, 2021 | 2.06 Mn |
| Sep 30, 2021 | 289,438.00 |
| Jun 30, 2021 | 289,680.00 |